Managing Erythromelalgia-Associated Pain with Suzetrigine: A Case Report

Don Hoang1, Jennifer Hubbell1, Thomas Verbeek1

  • 1Department of Anesthesiology and Perioperative Medicine, Penn State College of Medicine, Hershey, PA.

Summary

Suzetrigine, a selective Nav1.8 inhibitor, provided significant pain relief for a patient with erythromelalgia. This novel treatment shows promise for managing this debilitating chronic pain condition.